|
|
|
|
|
|
|
||
The Journal of General Physiology, Vol 98, 63-75, Copyright © 1991 by The Rockefeller University Press
ARTICLES |
RS Kass, JP Arena and S Chin
Department of Physiology, University of Rochester Medical Center, New York 14642.
We have studied block of L-type calcium channels by intracellular and extracellular application of the ionized dihydropyridine derivatives amlodipine and SDZ 207-180. We find that extracellular application of either drug causes voltage-dependent block of calcium channels. However, neither drug is effective when applied intracellularly. The insensitivity of calcium channels to intracellular drug is not due to the low concentrations of cytosolic calcium, because voltage-dependent block by ionized amlodipine, SDZ 207-180, and the neutral drug nisoldipine persists under conditions in which Ca0 is buffered by EGTA. In fact, the time course of the development of block by the ionized but not neutral drug molecules studied, is slower in the presence than in the absence of calcium. Our results indicate that the DHP binding site of the L-type calcium channel is close to the extracellular surface of the cell membrane and that ionized DHP molecules may interact with the receptor in a manner that is uniquely affected by calcium.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Bruhova, D. B. Tikhonov, and B. S. Zhorov Access and Binding of Local Anesthetics in the Closed Sodium Channel Mol. Pharmacol., October 1, 2008; 74(4): 1033 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Kumar, S. C. Stotz, R. Paramashivappa, A. M. Beedle, G. W. Zamponi, and A. S. Rao Synthesis and Evaluation of a New Class of Nifedipine Analogs with T-Type Calcium Channel Blocking Activity Mol. Pharmacol., March 1, 2002; 61(3): 649 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Blood, Y. Zhao, W. Long, L. Zhang, and L. D. Longo L-type Ca2+ channels in fetal and adult ovine cerebral arteries Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R131 - R138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Hockerman, B. Z. Peterson, E. Sharp, T. N. Tanada, T. Scheuer, and W. A. Catterall Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel PNAS, December 23, 1997; 94(26): 14906 - 14911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hering, S. Aczel, R. L. Kraus, S. Berjukow, J. Striessnig, and E. N. Timin Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: Role of inactivation PNAS, November 25, 1997; 94(24): 13323 - 13328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Z. Peterson, B. D. Johnson, G. H. Hockerman, M. Acheson, T. Scheuer, and W. A. Catterall Analysis of the Dihydropyridine Receptor Site of L-type Calcium Channels by Alanine-scanning Mutagenesis J. Biol. Chem., July 25, 1997; 272(30): 18752 - 18758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kurokawa, S. Adachi-Akahane, and T. Nagao 1,5-Benzothiazepine Binding Domain Is Located on the Extracellular Side of the Cardiac L-Type Ca2+ Channel Mol. Pharmacol., February 1, 1997; 51(2): 262 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Z. Peterson, T. N. Tanada, and W. A. Catterall Molecular Determinants of High Affinity Dihydropyridine Binding in L-type Calcium Channels J. Biol. Chem., March 8, 1996; 271(10): 5293 - 5296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamaguchi, Y. Okamura, T. Nagao, and S. Adachi-Akahane Serine Residue in the IIIS5-S6 Linker of the L-type Ca2+ Channel alpha 1C Subunit Is the Critical Determinant of the Action of Dihydropyridine Ca2+ Channel Agonists J. Biol. Chem., December 22, 2000; 275(52): 41504 - 41511. [Abstract] [Full Text] [PDF]
|
|
|
|
